Increased carotid artery intima-media thickness in subjects with primary hypoalphalipoproteinemia

Damiano Baldassarre1, Mauro Amato, Linda Pustina

  • 1Center E. Grossi Paoletti, Department of Pharmacological Sciences, University of Milan, Italy.

Insights

Low high-density lipoprotein cholesterol (HDL-C) is linked to increased atherosclerosis. This study found significantly greater carotid intima-media thickness in individuals with low HDL-C, but not in those with high HDL-C.

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Vascular Biology

Background:

  • Plasma high-density lipoprotein cholesterol (HDL-C) concentration shows an inverse correlation with atherosclerotic vascular events.
  • Understanding the relationship between HDL-C levels at the extremes of normal distribution and early atherosclerosis is crucial for cardiovascular risk assessment.

Purpose of the Study:

  • To evaluate pre-intrusive atherosclerosis in subjects with very low (hypoalphalipoproteinemia, HypoALP) or high (hyperalphalipoproteinemia, HyperALP) plasma HDL-C levels.
  • To compare carotid intima-media thickness (IMT) in these groups with control subjects and a large cohort of hyperlipidemic patients.

Main Methods:

  • Comparison of 55 HypoALP and 55 HyperALP subjects with 55 age-, sex-, and cholesterol-matched controls.
  • Measurement of average and maximal intima-media thickness (Avg-IMT and Max-IMT) across 48 carotid segments per subject.
  • Analysis of a large cohort (n=559) of hyperlipidemic subjects stratified by HDL-C quintiles.

Main Results:

  • Avg-IMT and Max-IMT were approximately 40% greater in HypoALP subjects compared to controls (P=0.004 and P=0.025, respectively).
  • IMT values in HyperALP subjects were comparable to those of control subjects.
  • In hyperlipidemic patients, significantly greater Avg-IMT and Max-IMT were observed in the lowest HDL-C quintile (<42 mg/dL) compared to other quintiles.

Conclusions:

  • Low HDL-C levels are associated with significant pre-intrusive atherosclerosis, indicated by increased carotid IMT.
  • Above-average HDL-C levels do not appear to confer additional protection against arterial wall thickening in this context.
  • These findings highlight the detrimental impact of low HDL-C on early atherosclerotic development.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...